These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18209894)

  • 21. Cutoff values for HOMA-IR associated with metabolic syndrome in the Study of Cardiovascular Risk in Adolescents (ERICA Study).
    Chissini RBC; Kuschnir MC; de Oliveira CL; Giannini DT; Santos B
    Nutrition; 2020 Mar; 71():110608. PubMed ID: 31783261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of insulin resistance and cardiometabolic risk in Korean children and adolescents: a population-based study.
    Yi KH; Hwang JS; Kim EY; Lee SH; Kim DH; Lim JS
    Diabetes Res Clin Pract; 2014 Jan; 103(1):106-13. PubMed ID: 24290751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of plasma glucose levels and traits of metabolic syndrome with carotid intima media thickness in nondiabetic elderly subjects: are they mediated by insulin resistance?
    Viscogliosi G; Andreozzi P; Marigliano V
    Metab Syndr Relat Disord; 2013 Feb; 11(1):41-5. PubMed ID: 23067236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort.
    McKeown NM; Meigs JB; Liu S; Saltzman E; Wilson PW; Jacques PF
    Diabetes Care; 2004 Feb; 27(2):538-46. PubMed ID: 14747241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sensitivity and specificity of metabolic syndrome criteria for insulin resistance diagnosis in Spanish population].
    Meriño-Ibarra E; Cenarro A; Martín P; García-Otín AL; Goicoechea J; Guallar A; Calvo L; Civeira F
    Med Clin (Barc); 2007 Feb; 128(5):168-71. PubMed ID: 17298777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis.
    Manco M; Marcellini M; Devito R; Comparcola D; Sartorelli MR; Nobili V
    Int J Obes (Lond); 2008 Feb; 32(2):381-7. PubMed ID: 18087267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals.
    Cordeiro A; Pereira SE; Saboya CJ; Ramalho A
    Biomed Res Int; 2015; 2015():839253. PubMed ID: 26120587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome and insulin resistance are associated with frailty in older adults: a prospective cohort study.
    Pérez-Tasigchana RF; León-Muñoz LM; Lopez-Garcia E; Gutierrez-Fisac JL; Laclaustra M; Rodríguez-Artalejo F; Guallar-Castillón P
    Age Ageing; 2017 Sep; 46(5):807-812. PubMed ID: 28338890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic interactions among metabolic syndrome components and homeostasis model assessment of insulin resistance in a middle-aged general population over time.
    Bonora BM; Marescotti M; Marcuzzo G; Avogaro A; Fadini GP
    Metab Syndr Relat Disord; 2015 May; 13(4):171-8. PubMed ID: 25734622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score.
    Srećković B; Soldatovic I; Colak E; Mrdovic I; Sumarac-Dumanovic M; Janeski H; Janeski N; Gacic J; Dimitrijevic-Sreckovic V
    Drug Metab Pers Ther; 2018 Jun; 33(2):99-103. PubMed ID: 29624500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.
    Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Alviggi L; Gnasso A; Consoli A; Cavalot F; Cavallo MG; Leonetti F; Giaccari A; Del Prato S;
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):699-705. PubMed ID: 21291660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers.
    Landucci Bonifácio K; Sabbatini Barbosa D; Gastaldello Moreira E; de Farias CC; Higachi L; Camargo AEI; Favaro Soares J; Odebrecht Vargas H; Nunes SOV; Berk M; Dodd S; Maes M
    J Affect Disord; 2017 Nov; 222():185-194. PubMed ID: 28710952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance.
    Meshkani R; Taghikhani M; Larijani B; Khatami S; Khoshbin E; Adeli K
    Clin Chim Acta; 2006 Sep; 371(1-2):169-75. PubMed ID: 16714005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity modifies the association between serum 25-hydroxyvitamin D and insulin resistance in Korean general population without increased fasting glucose levels.
    Lee SW; Kim M; Kim H; Han SS; Lee H; Lee JP; Kim DK; Lim CS; Kim YS; Park AK; Joo KW
    Tohoku J Exp Med; 2014 Oct; 234(2):89-97. PubMed ID: 25186304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthy Chilean Adolescents with HOMA-IR ≥ 2.6 Have Increased Cardiometabolic Risk: Association with Genetic, Biological, and Environmental Factors.
    Burrows R; Correa-Burrows P; Reyes M; Blanco E; Albala C; Gahagan S
    J Diabetes Res; 2015; 2015():783296. PubMed ID: 26273675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine is a marker for metabolic syndrome and atherosclerosis.
    Sreckovic B; Sreckovic VD; Soldatovic I; Colak E; Sumarac-Dumanovic M; Janeski H; Janeski N; Gacic J; Mrdovic I
    Diabetes Metab Syndr; 2017; 11(3):179-182. PubMed ID: 27600468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of several anthropometric measurements for the identification of metabolic syndrome, with or without disturbance of glucose metabolism].
    Rocha NP; Siqueira-Catania A; Barros CR; Pires MM; Folchetti LD; Ferreira SR
    Arq Bras Endocrinol Metabol; 2010 Oct; 54(7):636-43. PubMed ID: 21085769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.